These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2588512)

  • 1. [The effect of riboxin on lipid peroxidation in patients with acute myocardial infarct].
    Rudyk BI; Shved NI; Blinova NG; Sabadyshin RA; Gerasimets IM
    Vrach Delo; 1989 Aug; (8):14-5. PubMed ID: 2588512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of antioxidant therapy on lipid peroxidation in patients with acute and protracted pneumonia].
    Borovkova MS; Mashchakevich II
    Klin Med (Mosk); 1988 Dec; 66(12):62-4. PubMed ID: 3230853
    [No Abstract]   [Full Text] [Related]  

  • 3. [The efficacy of quinazopyrine, preparation E and riboxin in experimental myocardial infarct].
    Stets VR; Tishkin VS; Evdokimov EI
    Vrach Delo; 1989 Dec; (12):13-4. PubMed ID: 2483471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Riboxin treatment of peptic ulcer patients].
    Dorofeev GI; Sonina SI; Luft VM; Lisochkin BG; Marina AP
    Vrach Delo; 1984 Feb; (2):86-8. PubMed ID: 6719882
    [No Abstract]   [Full Text] [Related]  

  • 5. [The mechanism of action of riboxin].
    Dunaev VV; Tishkin VS; Evdokimov EI; Belaĭ IM
    Farmakol Toksikol; 1989; 52(6):56-8. PubMed ID: 2483141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of riboxin on visual function in glaucoma patients (experimental clinical study)].
    Iakovlev AA; Konde LA
    Vestn Oftalmol; 1982; (5):10-2. PubMed ID: 7147539
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of riboxin on hemodynamics and microcirculation in patients with chronic ischemic heart disease].
    Bondarenko IP
    Vrach Delo; 1983 Jan; (1):15-8. PubMed ID: 6868490
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of riboxin in the complex treatment of patients with acute pneumonia].
    Borovkova MS; Neĭko EM
    Vrach Delo; 1988 Apr; (4):85-7. PubMed ID: 3400234
    [No Abstract]   [Full Text] [Related]  

  • 9. [The results of the use of riboxin in the combined treatment of patients with pulmonary tuberculosis].
    Aleksandrova AE; Borisova LE; Vasil'ev AV
    Probl Tuberk; 1989; (9):28-33. PubMed ID: 2511573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The riboxin treatment of workers in the electron vacuum tube industry suffering from dermatoses].
    Shulipa IV; Turkevich IuN; Zaĭchenko AI
    Vestn Dermatol Venerol; 1990; (3):39-41. PubMed ID: 2142361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of the effect of riboxin].
    Kukes VG; Forova NM; Burian EF; Gneushev ET; Saprykina TD
    Sov Med; 1983; (2):84-6. PubMed ID: 6857353
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of cytoflavin for correction of complications of myocardial infarction].
    Bul'on VV; Khnychenko LK; Sapronov NS; Kovalenko AL; Alekseeva LE
    Eksp Klin Farmakol; 2002; 65(1):27-9. PubMed ID: 12025779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The oxidative stress produced by acute myocardial infarct and its repercussion on lipid peroxidation. The effect of thrombolytic therapy].
    Ribeiro H; Mendonça C; Monteiro CP; Nuno L; Pereira D; Rabaçal C; Carvalho E; Afonso JS; Laires MJ; Fernandes JS
    Rev Port Cardiol; 1995 Nov; 14(11):919-22. PubMed ID: 8541077
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiotropic activity of synthetic peptide CH3CO-Lys-Lys-Arg-Arg-NH2 (protectin)].
    Sazhin AI; Zaĭtseva MA; Melikhova ME; Ezhov NF; Sadovnikov VB; Navolotskaia EV
    Eksp Klin Farmakol; 2011; 74(6):14-9. PubMed ID: 21870769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical efficacy and outlook for the use of new drugs for metabolic therapy in dermatology].
    Kubanova AA; Khamaganova IV
    Vestn Dermatol Venerol; 1989; (3):57-60. PubMed ID: 2741548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of combined use of a lipid peroxidation inhibitor and a lymphatic drainage stimulant in intensive care of acute myocardial infarct].
    Garaev GSh; Mamedov IaD; Kurbanov IaZ; Ibragimli FI; Kasumova RM
    Anesteziol Reanimatol; 1993; (1):9-12. PubMed ID: 7943869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacodynamics of riboxin (inosine)].
    Frantsuzova SB; Krivelevich VIa; Parkhoniuk VP
    Farmakol Toksikol; 1989; 52(1):115-8. PubMed ID: 2651150
    [No Abstract]   [Full Text] [Related]  

  • 18. [Obzidan inhibition of lipid free-radical peroxidation in coronary-occluding myocardial infarct].
    Luk'ianova LO; Kudrin AN; Kogan AKh
    Farmakol Toksikol; 1983; 46(1):45-8. PubMed ID: 6825817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adenine nucleotide metabolism in acute myocardial infarct and the initiation of free-radical oxidation].
    Zhdanov GG; Sokolov IM
    Anesteziol Reanimatol; 1996; (3):25-7. PubMed ID: 8967612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antioxidant probucol as a regulator of the intensity of free-radical lipid peroxidation processes in the blood of patients with coronary atherosclerosis].
    Tikhaze AK; Lankin VZ; Mikhin VP; Revenko VM; Lupanov VP
    Ter Arkh; 1997; 69(9):35-41. PubMed ID: 9411823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.